About us
our story
Who we are
Your Trusted Partner for Swift, Reliable and Innovative Scientific Solutions.
Vision:
We pioneer innovative analytical solutions and mentor the next generation of scientists.
Why choose us:
With over 90 years of experience in CRO, Pharma and Clinical Markets, we’re respected innovators in the pharmaceutical and biotech industry. Outsourcing your analytical support to us offers flexibility, requiring less investment in personnel and infrastructure, strategically tailored to your business needs.
- Email
info@bioappsolutions.com - Address
Oak House, Limewood Business Park, Limewood Way, Leeds, LS14 1AB
The BioApp team
John Allanson
Chief Operating Officer
John, a bioanalyst with 40+ years of experience in Pharma and CROs, co-founded BioApp Solutions in 2015. He began his career at Hazleton Labs in 1982, later joining The Wellcome Foundation where he supported successful drug development programs, including migraine drug Zolmitriptan.
John led multidisciplinary teams, specialising in high sensitivity LC-MS/MS analysis of therapeutic peptides, drugs and biomarkers at York Bioanalytical Solutions. He also pioneered automated methodologies.
In addition to his leadership roles, John developed bioanalysis training programs and serves as a tutor for DMDG’s methods for bioanalysis and drug metabolism course.
Mohammed Abrar
Chief Scientific Officer
Abrar, an analytical chemist with 40+ years of experience, specialises in Mass Spectrometry since 1990. He co-founded BioApp Solutions in 2015, providing bioanalytical methods, consultancy and training.
Abrar’s expertise spans various roles, including pesticide residue chemist at Hazelton Labs, Technical Specialist at Covance and Method Development Manager at York Bioanalytical Solutions. He has a proven track record in implementing advanced instruments like Sciex API5500 Q-Trap and Water Xevo TQ-S, creating high sensitivity assays and serving international clients. He is also a tutor for DMDG’s bioanalysis and drug metabolism course.
Mira Doig
Bioanalytical Project Manager
Mira set up ABS Laboratories Ltd. in 1996 and led this small privately owned company to become a successful commercial bioanalytical contract research laboratory with GLP accreditation & GCP compliance. This company was purchased by ACM Global in 2018. Mira joined BioApp Solutions in 2023.
Prior to ABS she served as a Principal Scientist and Deputy Head at GlaxoWellcome (now GSK), overseeing a team of 70 supporting UK drug development from 1982-1996.
Mira’s contributions extend beyond her professional roles, including:
- A life membership at The British Mass Spectrometry Society (BMSS) in 2016.
- The Drug Metabolism Discussion Group (DMDG). Founded, co-organised and tutored on a biannual 5-day training course for The Drug Metabolism Discussion Group (DMDG), earning recognition in 2021.
- Actively, she participated in The European Bioanalytical Forum (EBF) working groups including microsampling and data integrity.
Rebecca Dowell
Research Scientist and Bioanalytical Project Manager
Rebecca joined BioApp Solutions in November 2021 after working at ABS Laboratories Ltd. (now ACM Global), where she began as an LC-MS/MS Scientist and progressed to Bioanalytical Study Director/Principal Investigator.
With over 5+ years experience working in a GLP and GCP accredited CRO, Rebecca excels at developing analytical methods, performing validation and sample extraction and managing various pre-clinical studies.
Humera Kouser
Research Scientist
Humera joined BioApp Solutions in July 2023 after working in a GLP, GMP and UKAS accredited CRO, where she progressed from a Scientist in regulatory testing to a Project Scientist in the scientific development team.
With over 3 years experience, she specialises in developing analytical methods and performing validations for small molecules using various techniques including LC-MS/MS.
Want to know more?
If you have any questions don’t hesitate to contact us.